Aromatase Inhibitors versus Tamoxifen for Pre-Menopausal Women Diagnosed With Early-Stage, Hormone Receptor-Positive Disease
At the 2021 San Antonio Breast Cancer Symposium, Rosie presented the results of their meta-analysis of four studies looking at effectiveness of aromatase inhibitors compared to tamoxifen in pre-menopausal women diagnosed with early-stage, hormone receptor-positive...
Breast Cancer Control Similar With Intermittent, Continuous Endocrine Therapy
Better quality of life with treatment break during extended adjuvant therapy Source: Breast Cancer Control Similar With Intermittent, Continuous Endocrine Therapy | MedPage Today
Breast cancer: Hundreds of chemicals identified as potential risk factors
Researchers find nearly 300 chemicals linked to breast cancer-contributing hormones in everyday products, and call for a renewed focus on women’s exposure risks. Source: Breast cancer: Hundreds of chemicals identified as potential risk factors –...
More Than 2 Years of Bisphosphonates for Early-Stage Breast Cancer Doesn’t Offer More Benefits
Receiving 3 to 5 years of bisphosphonate treatment after surgery and chemotherapy for early-stage breast cancer doesn’t improve survival any more than receiving 2 years of bisphosphonate treatment. Source: More Than 2 Years of Bisphosphonates for Early-Stage Breast...
Hormone therapy for breast cancer: How it works and more
Hormone therapy is a type of treatment for hormone-sensitive breast cancers. Learn more about how it works, side effects, alternatives, and more. Source: Hormone therapy for breast cancer: How it works and more
Study Details How Breast Cancer Becomes Resistant to Treatment
City of Hope has identified how cancer cells in patients with early-stage breast cancer change and become resistant to hormone or combination therapies, according to a new study published in Nature Cancer. Source: Study Details How Breast Cancer Becomes Resistant to...
Time to Reconsider Recs on Bisphosphonates for Breast Cancer?
“Concerns about adverse effects of prolonged bisphosphonate treatments, such as atypical bone fractures and osteonecrosis of the jaw, as well as results from both preclinical and clinical studies indicating that the benefit of bisphosphonates continues after...
Monitor CVD Risks in Cancer Patients on Hormonal Therapy
Patients undergoing hormone therapy for breast and prostate cancers may be at increased risk for cardiovascular disease (CVD) as they age and should be closely monitored for potential cardiovascular events, according to a scientific statement from the American Heart...People Taking Hormonal Therapy for Breast Cancer Have Higher Risk of Heart Disease, Monitoring Recommended
People taking hormonal therapy medicine to treat breast or prostate cancer have a higher risk of heart attack and stroke as they get older and should be monitored regularly to detect any problems, according to a scientific statement by the American Heart Association....
Digging Deeper into the Breast Cancer-Obesity Connection
New research from BCRF-supported researchers and others has shown that poor metabolic health is a much stronger predictor of breast cancer risk than body mass index (BMI)—an insight that could lead to personalized interventions. Read more on our blog. Source: AACR...
Review summarizes known links between endocrine disruptors and breast cancer risk
Exposure to certain endocrine-disrupting chemicals could elevate the risk of breast cancer, according to a new comprehensive systematic review of epidemiological research. Source: Review summarizes known links between endocrine disruptors and breast cancer risk...
Hormone Therapy for Breast Cancer Fact Sheet
Learn about the types of hormone therapy used to prevent and treat breast cancer (including antiestrogens, LH-RH agonists, aromatase inhibitors, and SERMs) and their possible side effects. Source: Hormone Therapy for Breast Cancer Fact Sheet – National Cancer...
Imaging Test to Guide Breast Cancer Treatment
For some people with ER-positive breast cancer, a new imaging test may one day help guide decisions about receiving hormone therapy, results from a small study show. The test uses an imaging tracer called FFNP that can show whether the estrogen receptors in tumors are...
Women Who Take An Estrogen Suppressing Drug For Up To 15 Years Could Reduce Breast Cancer Recurrence, Study Shows
The study examined 1,918 postmenopausal women split into two groups. Source: Women Who Take An Estrogen Suppressing Drug For Up To 15 Years Could Reduce Breast Cancer Recurrence, Study Shows | The Breast Cancer Site News
NCCN Now Recommends Breast Cancer Index for Predicting Benefit from Extended Endocrine Therapy
The Breast Cancer Index assay is the only of its kind to be recommended in the National Comprehensive Cancer Network Guidelines for the treatment of breast cancer as being predictive of extended adjuvant endocrine therapy. Source: NCCN Now Recommends Breast Cancer...
Breast cancer: Androgen therapy shows promise in preliminary study
New research suggests that androgen receptor-stimulating drugs may treat some forms of breast cancer more effectively than other therapies. Source: Breast cancer: Androgen therapy shows promise in preliminary study
Clinical Challenges: Acquired Endocrine Resistance in Breast Cancer
“Almost every patient will acquire resistance to endocrine therapy over time,” Rugo told MedPage Today. “Some patients will develop resistance in the first year of treatment — sometimes within months — and some can stay on their...
New estimates of breast cancer risks associated with HRT
A new study provides new estimates of the increased risks of breast cancer associated with use of different hormone replacement therapy (HRT) preparations. Source: New estimates of breast cancer risks associated with HRT – Nexus Newsfeed
Hormone Therapy Can Put Cancer Cells Into Sleep Mode And Cause A Relapse Years Afterwards
“Our findings suggest the drugs may kill some cells and switch others into this sleeper state. If we can unlock the secrets of these dormant cells, we may be able to find a way of preventing cancer coming back, either by holding the cells in permanent sleep mode, or...
Listen to Dr. Janet Maker's
Interview with Melanie Young
of Fearless Fabulous You
June 27, 2018 on W4WN Network
Listen to Dr. Janet Maker's Interview with Dr. Drew
June 4, 2018 on 790 KABC